{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:41:43Z","timestamp":1788309703030,"version":"build-2803163510"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2023,5,22]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To develop and validate the cut-offs in the Juvenile DermatoMyositis Activity Index (JDMAI) to distinguish the states of inactive disease (ID), low disease activity (LDA), moderate disease activity (MDA) and high disease activity (HDA) in children with juvenile dermatomyositis (JDM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>For cut-off definition, data from 139 patients included in a randomised clinical trial were used. Among the six versions of the JDMAI, JDMA1 (score range 0\u201340) and JDMAI2 (score range 0\u201339) were selected. Optimal cut-offs were determined against external criteria by calculating different percentiles of score distribution and through receiver operating characteristic curve analysis. External criteria included the modified Pediatric Rheumatology International Trials Organization (PRINTO) criteria for clinically ID in JDM (for ID) and PRINTO levels of improvement in the clinical trial (for LDA and HDA). MDA cut-offs were set at the score interval between LDA and HDA cut-offs. Cut-off validation was conducted by assessing construct and discriminative ability in two cohorts including a total of 488 JDM patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The calculated JDMAI1 cut-offs were \u22642.4 for ID, \u22646.6 for LDA, 6.7\u201311 for MDA and &gt;11 for HDA. The calculated JDMAI2 cut-offs were \u22645.2 for ID, \u22648.5 for LDA, 8.6\u201311.3 for MDA and &gt;11.3 for HDA. The cut-offs discriminated strongly among disease activity states defined subjectively by caring physicians and parents, parents\u2019 satisfaction or non-satisfaction with illness outcome, levels of pain, fatigue, physical functional impairment and physical well-being.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Both JDMAI1 and JDMAI2 cut-offs revealed good metrologic properties in validation analyses and are, therefore, suited for application in clinical practice and research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003093","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T13:06:38Z","timestamp":1706879198000},"page":"e003093","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3667-6155","authenticated-orcid":false,"given":"Silvia","family":"Rosina","sequence":"first","affiliation":[{"name":"UOC Reumatologia e Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Consolaro","sequence":"additional","affiliation":[{"name":"UOC Reumatologia e Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genova, Italy"},{"name":"Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal-Infantile Sciences (DiNOGMI), University of Genoa, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pistorio","sequence":"additional","affiliation":[{"name":"Direzione Scientifica, IRCCS Istituto Giannina Gaslini, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rebollo-Gim\u00e9nez","sequence":"additional","affiliation":[{"name":"UOC Reumatologia e Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9834-9619","authenticated-orcid":false,"given":"Claudia","family":"Bracaglia","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Ospedale Pediatrico Bambino Gesu, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Dolezalova","sequence":"additional","affiliation":[{"name":"1st Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Guilaisne Bernard-Medina","sequence":"additional","affiliation":[{"name":"Servicio de Reumatolog\u00eda, Hospital Civil de Guadalajara Unidad Hospitalaria Fray Antonio Alcalde, Guadalajara, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels","family":"Herlin","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology Unit, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trachana","sequence":"additional","affiliation":[{"name":"Thessaloniki University School of Medicine, First Department of Pediatrics, Pediatric Immunology and Rheumatology Referral Center, Hippokration General Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Vargov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Faculty of Medicine, Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice, Kosice, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Wouters","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology and Immune-inflammatory diseases, and KU Leuven - University of Leuven, Department of Microbiology and Immunology, Laboratory Immunobiology, UZ Leuven - Universitair ziekenhuis, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Carenini","sequence":"additional","affiliation":[{"name":"UOC Servizio Sperimentazioni Cliniche Pediatriche, IRCCS Istituto Giannina Gaslini, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8407-7782","authenticated-orcid":false,"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[{"name":"UOC Servizio Sperimentazioni Cliniche Pediatriche, IRCCS Istituto Giannina Gaslini, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9658-0385","authenticated-orcid":false,"given":"Angelo","family":"Ravelli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal-Infantile Sciences (DiNOGMI), University of Genoa, Genova, Italy"},{"name":"Direzione Scientifica, IRCCS Istituto Giannina Gaslini, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"key":"2025090313510233000_10.1.e003093.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60955-1"},{"key":"2025090313510233000_10.1.e003093.2","doi-asserted-by":"crossref","unstructured":"Rider L , Lidsley C , Miller F . Juvenile dermatomyositis. In: Textbook of pediatric rheumatology. 2016: 351\u201384.","DOI":"10.1016\/B978-0-323-24145-8.00026-0"},{"key":"2025090313510233000_10.1.e003093.3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313510233000_10.1.e003093.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.24904"},{"key":"2025090313510233000_10.1.e003093.5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/acr.21637","article-title":"Quality of life in adults with juvenile-onset dermatomyositis: a case-control study","volume":"64","author":"Tollisen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313510233000_10.1.e003093.6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acr.20203","article-title":"Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: a case-control study","volume":"62","author":"Sanner","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313510233000_10.1.e003093.7","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/acr.20280","article-title":"The paediatric rheumatology international trials organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313510233000_10.1.e003093.8","doi-asserted-by":"crossref","first-page":"SI163","DOI":"10.1093\/rheumatology\/keac404","article-title":"Experience with the use of mycophenolate mofetil in juvenile idiopathic inflammatory myopathies","volume":"62","author":"Varnier","year":"2023","journal-title":"Rheumatology"},{"key":"2025090313510233000_10.1.e003093.9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.55563\/clinexprheumatol\/ltrj4l","article-title":"A systematic review on biological therapies in juvenile idiopathic inflammatory myopathies: an evidence gap in precision medicine","volume":"40","author":"Marrani","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313510233000_10.1.e003093.10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/art.42450","article-title":"Improvement in disease activity in refractory juvenile dermatomyositis following abatacept therapy","volume":"75","author":"Curiel","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2025090313510233000_10.1.e003093.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.37754"},{"key":"2025090313510233000_10.1.e003093.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01021-1"},{"key":"2025090313510233000_10.1.e003093.13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a children\u2019s arthritis and rheumatology research alliance consensus conference","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313510233000_10.1.e003093.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212141"},{"key":"2025090313510233000_10.1.e003093.15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/rheumatology\/key366","article-title":"Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib","volume":"58","author":"Moghadam-Kia","year":"2019","journal-title":"Rheumatology"},{"key":"2025090313510233000_10.1.e003093.16","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/rheumatology\/key421","article-title":"Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis","volume":"58","author":"Rosina","year":"2019","journal-title":"Rheumatology"},{"key":"2025090313510233000_10.1.e003093.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.24516"},{"key":"2025090313510233000_10.1.e003093.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204186"},{"key":"2025090313510233000_10.1.e003093.19","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/art.41879","article-title":"Definition and validation of the American College of Rheumatology 2021 juvenile arthritis disease activity score cutoffs for disease activity states in juvenile idiopathic arthritis","volume":"73","author":"Trincianti","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025090313510233000_10.1.e003093.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.34373"},{"key":"2025090313510233000_10.1.e003093.21","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/acr.22393","article-title":"Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score","volume":"66","author":"Consolaro","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313510233000_10.1.e003093.22","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/acr.23491","article-title":"Development and testing of a hybrid measure of muscle strength in juvenile dermatomyositis for use in routine care","volume":"70","author":"Varnier","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313510233000_10.1.e003093.23","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8"},{"key":"2025090313510233000_10.1.e003093.24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20035","article-title":"Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies","volume":"62","author":"Rider","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313510233000_10.1.e003093.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.20179"},{"key":"2025090313510233000_10.1.e003093.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.10924"},{"key":"2025090313510233000_10.1.e003093.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201483"},{"key":"2025090313510233000_10.1.e003093.28","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.39200","article-title":"Analysis of Published criteria for clinically inactive disease in a large juvenile dermatomyositis cohort shows that skin disease is underestimated","volume":"67","author":"Almeida","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025090313510233000_10.1.e003093.29","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110745"},{"key":"2025090313510233000_10.1.e003093.30","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780371209"},{"key":"2025090313510233000_10.1.e003093.31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg427"},{"key":"2025090313510233000_10.1.e003093.32","unstructured":"Landgraf J , Abetz L , Ware J . The CHQ User\u2019s Manual. 1st ed. Boston, MA, USA: The Health InstituteNew England Medical Center, 1996."},{"key":"2025090313510233000_10.1.e003093.33","first-page":"S1","article-title":"Cross-cultural adaptation and psychometric evaluation of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ) in 32 countries. Review of the general methodology","volume":"19","author":"Ruperto","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313510233000_10.1.e003093.34","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg403"},{"key":"2025090313510233000_10.1.e003093.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.23248"},{"key":"2025090313510233000_10.1.e003093.36","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-018-0734-4","article-title":"Innovative research design to meet the challenges of clinical trials for juvenile dermatomyositis","volume":"20","author":"Rosina","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"2025090313510233000_10.1.e003093.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.03.004"},{"key":"2025090313510233000_10.1.e003093.38","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep078"},{"key":"2025090313510233000_10.1.e003093.39","doi-asserted-by":"publisher","DOI":"10.1186\/ar4198"},{"key":"2025090313510233000_10.1.e003093.40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrrheum.2014.208","article-title":"Advances in biomarkers for paediatric rheumatic diseases","volume":"11","author":"Consolaro","year":"2015","journal-title":"Nat Rev Rheumatol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:51:09Z","timestamp":1756932669000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2,2]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/rmdopen-2023-003093"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003093","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}